Yuzo Koda

972 total citations · 1 hit paper
14 papers, 312 citations indexed

About

Yuzo Koda is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Yuzo Koda has authored 14 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Yuzo Koda's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (5 papers) and Liver Diseases and Immunity (5 papers). Yuzo Koda is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (5 papers) and Liver Diseases and Immunity (5 papers). Yuzo Koda collaborates with scholars based in Japan. Yuzo Koda's co-authors include Takanori Kanai∥, Nobuhiro Nakamoto, Kentaro Miyamoto, Toshiaki Teratani, Nobuhito Taniki, Po–Sung Chu, Yohei Mikami, Tomohisa Sujino, Takahiro Suzuki and Michiie Sakamoto and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Yuzo Koda

12 papers receiving 309 citations

Hit Papers

CD8+ tissue-resident memory T cells promote liver fibrosi... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzo Koda Japan 8 140 119 104 79 43 14 312
Taizo Mori Japan 11 139 1.0× 80 0.7× 103 1.0× 50 0.6× 32 0.7× 25 284
Adélaïde Gélineau France 5 163 1.2× 136 1.1× 76 0.7× 94 1.2× 39 0.9× 5 340
Jin-Seok Byun South Korea 8 165 1.2× 122 1.0× 154 1.5× 65 0.8× 18 0.4× 9 351
Morgane Mabire France 6 189 1.4× 165 1.4× 111 1.1× 49 0.6× 32 0.7× 9 364
Kim Olievier Belgium 8 134 1.0× 84 0.7× 91 0.9× 118 1.5× 54 1.3× 10 358
G. Marquitan Germany 10 207 1.5× 80 0.7× 122 1.2× 132 1.7× 56 1.3× 12 386
Takashi Saito Japan 9 107 0.8× 142 1.2× 54 0.5× 73 0.9× 41 1.0× 19 356
Emelie Barreby Sweden 5 154 1.1× 73 0.6× 49 0.5× 97 1.2× 20 0.5× 5 265
Ruidong Mo China 9 263 1.9× 84 0.7× 179 1.7× 49 0.6× 25 0.6× 15 392
Hufeng Xu China 10 70 0.5× 121 1.0× 35 0.3× 89 1.1× 26 0.6× 17 302

Countries citing papers authored by Yuzo Koda

Since Specialization
Citations

This map shows the geographic impact of Yuzo Koda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzo Koda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzo Koda more than expected).

Fields of papers citing papers by Yuzo Koda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzo Koda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzo Koda. The network helps show where Yuzo Koda may publish in the future.

Co-authorship network of co-authors of Yuzo Koda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzo Koda. A scholar is included among the top collaborators of Yuzo Koda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzo Koda. Yuzo Koda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Koda, Yuzo, et al.. (2025). The impact of T cells on immune-related liver diseases: an overview. Inflammation and Regeneration. 45(1). 21–21.
2.
Ono, Satoshi, Masahiro Hiraizumi, Kouji Tanaka, et al.. (2024). Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor. Bioorganic & Medicinal Chemistry. 109. 117790–117790. 1 indexed citations
3.
Chu, Po–Sung, Nobuhiro Nakamoto, Yuya Hagihara, et al.. (2023). Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 26(3). 106220–106220. 7 indexed citations
4.
Chu, Po–Sung, Toshiaki Teratani, Yosuke Harada, et al.. (2023). IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 5(7). 100757–100757. 3 indexed citations
5.
Chu, Po–Sung, Yuzo Koda, Nobuhito Taniki, et al.. (2022). Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts. PLoS ONE. 17(10). e0276925–e0276925.
6.
Koda, Yuzo, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2022). CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury. JCI Insight. 7(17). 5 indexed citations
7.
Koda, Yuzo, Nobuhiro Nakamoto, & Takanori Kanai∥. (2022). Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells. Seminars in Liver Disease. 42(4). 475–488. 11 indexed citations
8.
Nakamoto, Nobuhiro, Junichiro Irie, Nobuhito Taniki, et al.. (2021). C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice. Diabetologia. 64(3). 603–617. 10 indexed citations
9.
Koda, Yuzo, Toshiaki Teratani, Po–Sung Chu, et al.. (2021). CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nature Communications. 12(1). 4474–4474. 147 indexed citations breakdown →
10.
Morikawa, Rei, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2020). Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Journal of Hepatology. 74(3). 511–521. 30 indexed citations
11.
Koda, Yuzo, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2019). Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35. Journal of Clinical Investigation. 129(8). 3201–3213. 29 indexed citations
12.
Tachibana, Masashi, Nobumasa Watanabe, Yuzo Koda, et al.. (2019). Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production. International Immunology. 32(3). 187–201. 15 indexed citations
13.
Kiyohara, Hiroki, Tomohisa Sujino, Toshiaki Teratani, et al.. (2018). Toll-Like Receptor 7 Agonist–Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cellular and Molecular Gastroenterology and Hepatology. 7(1). 135–156. 38 indexed citations
14.
Murakami, Yuko, Kazuo Sugiyama, Hirotoshi Ebinuma, et al.. (2018). Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells. BMC Cancer. 18(1). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026